New methods in tissue engineering: Improved models for viral infection

Annual Review of Virology

Volumn 1, Issue 1, 2014, Pages 475-499

  Ramanan, Vyas ^a   Scull, Margaret A ^d   Sheahan, Timothy P ^d   Rice, Charles M ^d   Bhatia, Sangeeta N ^a,b,c,e,f  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b Department of Electrical Engineering and Computer Science   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Cell cell interactions; Complexity; Hepatotropic viruses; Host pathogen interactions; Patterning; Primary cells

Indexed keywords

BIOMATERIAL; GROWTH FACTOR; PROTEINASE; VASCULOTROPIN; VIRUS DNA;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL IMMORTALIZATION; CELL ISOLATION; CELL POLARITY; CELLS BY BODY ANATOMY; CYTOARCHITECTURE; DATA COLLECTION METHOD; EXTRACELLULAR MATRIX; HERPES SIMPLEX VIRUS 1; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MONOLAYER CULTURE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PATHOGENESIS; PHENOTYPE; PRIMARY CELL; PRIMARY CELL CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STANDARDIZATION; SUSPENSION CELL CULTURE; TISSUE CULTURE; TISSUE ENGINEERING; VIROLOGY; VIRUS; VIRUS INFECTION; VIRUS STRAIN;

ANIMALIA;

EID: 85016941865     PISSN: 2327056X     EISSN: 23270578     Source Type: Journal    
DOI: 10.1146/annurev-virology-031413-085437     Document Type: Article

References (210)

1. Carrel A. 1912. On the permanent life of tissues outside of the organism. J. Exp. Med. 15:516-28
2. Carrel A. 1923. A method for the physiological study of tissues in vitro. J. Exp. Med. 38:407-18
3. Steinhardt L, Israeli C, Lambert RA. 1913. Studies on the cultivation of the virus of vaccinia. J. Infect. Dis. 13:294-300
4. Haagen E, Theiler M. 1932. Studies of yellow fever virus in tissue culture. Proc. Soc. Exp. Biol. Med. 29:435-36
5. Enders JF, Weller TH, Robbins FC. 1949. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109:85-87
6. Gey GO, CoffmanWD, KubicekMT. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:264-65
7. Dvir T, Timko BP, Kohane DS, Langer R. 2011. Nanotechnological strategies for engineering complex tissues. Nat. Nanotechnol. 6:13-22
8. Griffith LG, Naughton G. 2002. Tissue engineering-current challenges and expanding opportunities. Science 295:1009-14
9. Bianco P, Robey PG. 2001. Stem cells in tissue engineering. Nature 414:118-21
10. Carletti E, Motta A, Migliaresi C. 2011. Scaffolds for tissue engineering and 3D cell culture. Methods Mol. Biol. 695:17-39
11. LeeK, Silva EA, Mooney DJ. 2011. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J. R. Soc. Interface 8:153-70
12. Griffith LG, Swartz MA. 2006. Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell Biol. 7:211-24
13. Khan OF, Sefton MV. 2011. Endothelialized biomaterials for tissue engineering applications in vivo. Trends Biotechnol. 29:379-87
14. Chen AA, Thomas DK, Ong LL, Schwartz RE, Golub TR, Bhatia SN. 2011. Humanized mice with ectopic artificial liver tissues. Proc. Natl. Acad. Sci. USA 108:11842-47
15. Shan J, Stevens KR, Trehan K, Underhill GH, Chen AA, Bhatia SN. 2011. Hepatic tissue engineering. In Molecular Pathology of Liver Diseases, ed. SPS Monga, pp. 321-42. New York: Springer
16. Schmidt CE, Leach JB. 2003. Neural tissue engineering: strategies for repair and regeneration. Annu. Rev. Biomed. Eng. 5:293-347
17. Laflamme MA, Murry CE. 2011. Heart regeneration. Nature 473:326-35
18. Stevens KR, Ungrin MD, Schwartz RE, Ng S, Carvalho B, et al. 2013. InVERT molding for scalable control of tissue microarchitecture. Nat. Commun. 4:1847
19. Guvendiren M, Perepelyuk M,Wells RG, Burdick JA. 2013. Hydrogels with differential and patterned mechanics to study stiffness-mediated myofibroblastic differentiation of hepatic stellate cells. J. Mech. Behav. Biomed. Mater. In press. doi: 10.1016/j.jmbbm.2013.11.008
20. Dickinson LE, Kusuma S, Gerecht S. 2011. Reconstructing the differentiation niche of embryonic stem cells using biomaterials. Macromol. Biosci. 11:36-49
21. Takebe T, Sekine K, EnomuraM, Koike H, Kimura M, et al. 2013. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499:481-84
22. Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, et al. 2013. Cerebral organoids model human brain development and microcephaly. Nature 501:373-79
23. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, et al. 2009. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:262-65
24. Stevens KR, Kreutziger KL, Dupras SK, Korte FS, Regnier M, et al. 2009. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc. Natl. Acad. Sci. USA 106:16568-73
25. Ahmed TAE, Dare EV, Hincke M. 2008. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng. B 14:199-215
26. Parenteau-Bareil R, Gauvin R, Berthod F. 2010. Collagen-based biomaterials for tissue engineering applications. Materials 3:1863-87
27. Burdick JA, Prestwich GD. 2011. Hyaluronic acid hydrogels for biomedical applications. Adv. Mater. 23:H41-56
28. LeeKY, Mooney DJ. 2012. Alginate: properties and biomedical applications. Prog. Polymer Sci. 37:106-26
29. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, et al. 2007. Engineering tumors with 3D scaffolds. Nat. Methods 4:855-60
30. Pan Z,Ding JD. 2012. Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine. Interface Focus 2:366-77
31. Kloxin AM, Kasko AM, Salinas CN, Anseth KS. 2009. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 324:59-63
32. LutolfMP, Hubbell JA. 2005. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23:47-55
33. Zhang L, Cao Z, Bai T, Carr L, Ella-Menye JR, et al. 2013. Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nat. Biotechnol. 31:553-56
34. Anderson DG, Levenberg S, Langer R. 2004. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat. Biotechnol. 22:863-66
35. Lei Y, Schaffer DV. 2013. A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc. Natl. Acad. Sci. USA 110:E5039-48
36. Brown AC, Rowe JA, Barker TH. 2011. Guiding epithelial cell phenotypes with engineered integrinspecific recombinant fibronectin fragments. Tissue Eng. A 17:139-50
37. Gauvin R, Chen YC, Lee JW, Soman P, Zorlutuna P, et al. 2012. Microfabrication of complex porous tissue engineering scaffolds using 3D projection stereolithography. Biomaterials 33:3824-34
38. Martino MM, Briquez PS, Ranga A, Lutolf MP, Hubbell JA. 2013. Heparin-binding domain of fibrin( ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc. Natl. Acad. Sci. USA 110:4563-68
39. Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, et al. 2010. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc. Natl. Acad. Sci. USA 107:3287-92
40. Martino MM, Tortelli F, Mochizuki M, Traub S, Ben-David D, et al. 2011. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med. 3:100ra89
41. Yang K, Lee JS, Kim J, Lee YB, Shin H, et al. 2012. Polydopamine-mediated surface modification of scaffold materials for human neural stem cell engineering. Biomaterials 33:6952-64
42. YuenWW,Du NR, Chan CH, Silva EA, Mooney DJ. 2010. Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones. Proc. Natl. Acad. Sci. USA 107:17933-38
43. Chung BG, Flanagan LA, Rhee SW, Schwartz PH, Lee AP, et al. 2005. Human neural stem cell growth and differentiation in a gradient-generating microfluidic device. Lab Chip 5:401-6
44. Mohyeldin A, Garzon-Muvdi T, Quinones-Hinojosa A. 2010. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7:150-61
45. Inoguchi H, Tanaka T, Maehara Y, Matsuda T. 2007. The effect of gradually graded shear stress on the morphological integrity of a HUVEC-seeded compliant small-diameter vascular graft. Biomaterials 28:486-95
46. Powers MJ, Domansky K, Kaazempur-MofradMR, Kalezi A, Capitano A, et al. 2002. A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol. Bioeng. 78:257-69
47. Ruiz SA, Chen CS. 2007. Microcontact printing: a tool to pattern. Soft Matter 3:168-77
48. Albrecht DR, Underhill GH,Wassermann TB, Sah RL, Bhatia SN. 2006. Probing the role of multicellular organization in three-dimensional microenvironments. Nat. Methods 3:369-75
49. Miller JS, Stevens KR, Yang MT, Baker BM, Nguyen DHT, et al. 2012. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat. Mater. 11:768-74
50. Lim SH, MaoHQ. 2009. Electrospun scaffolds for stem cell engineering. Adv. Drug Deliv. Rev. 61:1084-96
51. Katz JS,Burdick JA. 2010. Light-responsive biomaterials: development and applications. Macromol. Biosci. 10:339-48
52. Li CY, Wood DK, Hsu CM, Bhatia SN. 2011. DNA-templated assembly of droplet-derived PEG microtissues. Lab Chip 11:2967-75
53. Yeh J, Ling Y, Karp JM, Gantz J, Chandawarker A, et al. 2006. Micromolding of shape-controlled, harvestable hydrogels. Biomaterials 27:5391-98
54. Malda J, Visser J,Melchels FP, JuengstT,Hennink WE, et al. 2013. 25th anniversary article: engineering hydrogels for biofabrication. Adv. Mater. 25:5011-28
55. Baranski JD, Chaturvedi RR, Stevens KR, Eyckmans J, Carvalho B, et al. 2013. Geometric control of vascular networks to enhance engineered tissue integration and function. Proc. Natl. Acad. Sci. USA 110:7586-91
56. Kim K, Ohashi K, Utoh R, Kano K, Okano T. 2012. Preserved liver-specific functions of hepatocytes in 3D co-culture with endothelial cell sheets. Biomaterials 33:1406-13
57. Khetani SR, Bhatia SN. 2008. Microscale culture of human liver cells for drug development. Nat. Biotechnol. 26:120-26
58. Zinchenko YS, Schrum LW, Clemens M, Coger RN. 2006. Hepatocyte and Kupffer cells co-cultured on micropatterned surfaces to optimize hepatocyte function. Tissue Eng. 12:751-61
59. Ganesan LP, Mohanty S, Kim J, Clark KR, Robinson JM, Anderson CL. 2011. Rapid and efficient clearance of blood-borne virus by liver sinusoidal endothelium. PLoS Pathog. 7:e1002281
60. Cormier EG, Durso RJ, Tsamis F, Boussemart L, Manix C, et al. 2004. L-SIGN (CD209L) and DC-SIGN (0209) mediate transinfection of liver cells by hepatitis C virus. Proc. Natl. Acad. Sci. USA 101:14067-72
61. Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, et al. 2007. Viral and host factors induce macrophage activation and loss of Toll-like receptor tolerance in chronicHCVinfection. Gastroenterology 133:1627-36
62. Wu J, Meng Z, JiangM, Pei R, Trippler M, et al. 2009. Hepatitis B virus suppresses Toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49:1132-40
63. Choi NW, Cabodi M, Held B, Gleghorn JP, Bonassar LJ, Stroock AD. 2007. Microfluidic scaffolds for tissue engineering. Nat. Mater. 6:908-15
64. Tomei AA, Siegert S, Britschgi MR, Luther SA, Swartz MA. 2009. Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment. J. Immunol. 183:4273-83
65. Murphy BR,Whitehead SS. 2011. Immune response to dengue virus and prospects for a vaccine. Annu. Rev. Immunol. 29:587-619
66. Phillips JE, BurnsKL, Le Doux JM,Guldberg RE,Garcia AJ. 2008. Engineering graded tissue interfaces. Proc. Natl. Acad. Sci. USA 105:12170-75
67. Glorieux S, Bachert C, Favoreel HW, Vandekerckhove AP, Steukers L, et al. 2011. Herpes simplex virus type 1 penetrates the basement membrane in human nasal respiratory mucosa. PLoS ONE 6:e22160
68. Hogk I, Rupp S, Burger-Kentischer A. 2013. 3D-tissue model for herpes simplex virus-1 infections. Methods Mol. Biol. 1064:239-51
69. Ibricevic A, Pekosz A,Walter MJ, Newby C, Battaile JT, et al. 2006. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J. Virol. 80:7469-80
70. Ehre C, Worthington EN, Liesman RM, Grubb BR, Barbier D, et al. 2012. Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. Proc. Natl. Acad. Sci. USA 109:16528-33
71. Wyckoff J, Wang WG, Lin EY, Wang YR, Pixley F, et al. 2004. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64:7022-29
72. Kidd ME, Shin S, Shea LD. 2012. Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo. J. Controlled Release 157:80-85
73. Thomas AM, Shea LD. 2013. Polysaccharide-modified scaffolds for controlled lentivirus delivery in vitro and after spinal cord injury. J. Controlled Release 170:421-29
74. Castleberry S, Wang M, Hammond PT. 2013. Nanolayered siRNA dressing for sustained localized knockdown. ACS Nano 7:5251-61
75. Jindal R, Patel SJ, Yarmush ML. 2011. Tissue-engineered model for real-time monitoring of liver inflammation. Tissue Eng. C 17:113-22
76. Smith LE, Smallwood R, Macneil S. 2010. A comparison of imaging methodologies for 3D tissue engineering. Microsc. Res. Tech. 73:1123-33
77. Hong CS, Fellows W, Niranjan A, Alber S, Watkins S, et al. 2010. Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection. Gene Ther. 17:1200-5
78. Valyi-Nagy K, Dosa S, Kovacs SK, Bacsa S, Voros A, et al. 2010. Identification of virus resistant tumor cell subpopulations in three-dimensional uveal melanoma cultures. Cancer Gene Ther. 17:223-34
79. Huh D, Hamilton GA, Ingber DE. 2011. From 3D cell culture to organs-on-chips. Trends Cell Biol. 21:745-54
80. Kim HJ, Huh D, Hamilton G, Ingber DE. 2012. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12:2165-74
81. Nichols JE, Cortiella J, Lee J, Niles JA, Cuddihy M, et al. 2009. In vitro analog of human bone marrow from 3D scaffolds with biomimetic inverted colloidal crystal geometry. Biomaterials 30:1071-79
82. Hadziyannis SJ, Vassilopoulos D, Hadziyannis E. 2013. The natural course of chronic hepatitis B virus infection and its management. Antivir. Agents 67:247-91
83. Yamane D, McGivernDR, Masaki T, Lemon SM. 2013. Liver injury and disease pathogenesis in chronic hepatitis C. Curr. Top. Microbiol. Immunol. 369:263-88
84. Wedemeyer H, Pischke S, Manns MP. 2012. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology 142:1388-97
85. Martin A, Lemon SM. 2006. Hepatitis A virus: from discovery to vaccines. Hepatology 43:S164-72
86. Pavio N,Meng XJ, Renou C. 2010. Zoonotic hepatitis E: animal reservoirs and emerging risks. Vet. Res. 41:46
87. vonWeizsäcker F, Roggendorf M, eds. 2005. Models of Viral Hepatitis. Basel: Karger
88. Jopling CL, Yi MK, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577-81
89. Tang H, McLachlan A. 2001. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc. Natl. Acad. Sci. USA 98:1841-46
90. Konduru K, Kaplan GG. 2006. Stable growth of wild-type hepatitis A virus in cell culture. J. Virol. 80:1352-60
91. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-26
92. Gottwein JM, Bukh J. 2008. Cutting the Gordian knot-development and biological relevance of hepatitis C virus cell culture systems. Adv. Virus Res. 71:51-133
93. Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-13
94. Saeed M, Scheel TKH, Gottwein JM, Marukian S, Dustin LB, et al. 2012. Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells. Antimicrob. Agents Chemother. 56:5365-73
95. Bartosch B, Dubuisson J, Cosset FL. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197:633-42
96. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, et al. 2006. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. USA 103:7408-13
97. Tanaka T, Takahashi M, Kusano E, Okamoto H. 2007. Development and evaluation of an efficient cell-culture system for hepatitis E virus. J. Gen. Virol. 88:903-11
98. Tanaka T, Takahashi M, Takahashi H, Ichiyama K, Hoshino Y, et al. 2009. Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient. J. Clin. Microbiol. 47:1906-10
99. Emerson SU, Zhang M, Meng XJ, Nguyen H, St Claire M, et al. 2001. Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc. Natl. Acad. Sci. USA 98:15270-75
100. Huang YW, Haqshenas G, Kasorndorkbua C, Halbur PG, Emerson SU, Meng XJ. 2005. Capped RNA transcripts of full-length cDNA clones of swine hepatitis E virus are replication competent when transfected intoHuh7 cells and infectious when intrahepatically inoculated into pigs. J. Virol. 79:1552-58
101. Sells MA, Chen ML, Acs G. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84:1005-9
102. ParanN,Geiger B, Shaul Y. 2001.HBVinfection of cell culture: evidence for multivalent and cooperative attachment. EMBO J. 20:4443-53
103. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399-401
104. Thomas DL, Thio CL, Martin MP,Qi Y,GeD, et al. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798-801
105. Aizaki H, Nagamori S, Matsuda M, Kawakami H, Hashimoto O, et al. 2003. Production and release of infectious hepatitisCvirus from human liver cell cultures in the three-dimensional radial-flow bioreactor. Virology 314:16-25
106. Aly HH, Shimotohno K, Hijikata M. 2009. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV. Biochem. Biophys. Res. Commun. 379:330-34
107. Aly HH, Qi Y, Atsuzawa K, Usuda N, Takada Y, et al. 2009. Strain-dependent viral dynamics and viruscell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus. Hepatology 50:689-96
108. Mizumoto H, Ishihara K, Nakazawa K, Ijima H, Funatsu K, Kajiwara T. 2008. New culture technique for hepatocyte organoid formation and long-term maintenance of liver-specific functions. Tissue Eng. C 14:167-75
109. Ndongo-Thiam N, Berthillon P, Errazuriz E, Bordes I, De Sequeira S, et al. 2011. Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes. Hepatology 54:406-17
110. Narbus CM, Israelow B, Sourisseau M, Michta ML, Hopcraft SE, et al. 2011. HepG2 Cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J. Virol. 85:12087-92
111. Sainz B Jr, TenCate V, Uprichard SL. 2009. Three-dimensional Huh7 cell culture system for the study of hepatitis C virus infection. Virol. J. 6:103
112. Sainz B Jr, Chisari FV. 2006. Production of infectious hepatitis C virus by well-differentiated, growtharrested human hepatoma-derived cells. J. Virol. 80:10253-57
113. Murakami K, Ishii K, Ishihara Y, Yoshizaki S, Tanaka K, et al. 2006. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b. Virology 351:381-92
114. Molina-Jimenez F, Benedicto I, Dao Thi VL, Gondar V, Lavillette D, et al. 2012. Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle. Virology 425:31-39
115. Cho NJ, Elazar M, Xiong AM, Lee W, Chiao E, et al. 2009. Viral infection of human progenitor and liver-derived cells encapsulated in three-dimensional PEG-based hydrogel. Biomed. Mater. 4:011001
116. Rumin S, Berthillon P, Tanaka E, Kiyosawa K, Trabaud MA, et al. 1999. Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. J. Gen. Virol. 80:3007-18
117. Steenbergen RHG, Joyce MA, Thomas BS, Jones D, Law J, et al. 2013. Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers. Hepatology 58:1907-17
118. Berto A, Van der Poel WHM, Hakze-van der Honing R, Martelli F, La Ragione RM, et al. 2013. Replication of hepatitis E virus in three-dimensional cell culture. J. Virol. Methods 187:327-32
119. Rogée S, Talbot N, Caperna T, Bouquet J, Barnaud E, Pavio N. 2013. New models of hepatitis E virus replication in human and porcine hepatocyte cell lines. J. Gen. Virol. 94:549-58
120. Blank CA, Anderson DA, Beard M, Lemon SM. 2000. Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: vectorial release of progeny virions through apical cellular membranes. J. Virol. 74:6476-84
121. Snooks MJ, Bhat P, Mackenzie J, Counihan NA, Vaughan N, Anderson DA. 2008. Vectorial entry and release of hepatitis A virus in polarized human hepatocytes. J. Virol. 82:8733-42
122. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, et al. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-5
123. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, et al. 2009. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882-86
124. Sourisseau M, Michta ML, Zony C, Israelow B, Hopcraft SE, et al. 2013. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. PLoS Pathog. 9:e1003244
125. Schulze A, Mills K, Weiss TS, Urban S. 2012. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 55:373-83
126. Mee CJ, Grove J, Harris HJ, Hu K, Balfe P,McKeating JA. 2008. Effect of cell polarization on hepatitis C virus entry. J. Virol. 82:461-70
127. MeeCJ, Farquhar MJ,HarrisHJ, Hu K, Ramma W, et al. 2010. HepatitisCvirus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Gastroenterology 138:1134-42
128. Timpe JM, Stamataki Z, Jennings A, Hu K, Farquhar MJ, et al. 2008. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47:17-24
129. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, et al. 2002. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 99:15655-60
130. Yan H, Zhong G, Xu G, He W, Jing Z, et al. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1:e00049
131. Yi N, Lempp FA, Mehrle S, Nkongolo S,Kaufman C, et al. 2013. HepatitisBandDviruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146:1070-83
132. Quasdorff M, Hoesel M, Odenthal M, Zedler U, Bohne F, et al. 2008. A concerted action of HNF4α and HNF1αlinks hepatitis B virus replication to hepatocyte differentiation. Cell. Microbiol. 10:1478-90
133. Bhatia SN, Balis UJ, Yarmush ML, Toner M. 1999. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J. 13:1883-900
134. Iacovacci S, Manzin A, Barca S, Sargiacomo M, Serafino A, et al. 1997. Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology 26:1328-37
135. Lin M, Chen Q, Yang LY, Li WY, Cao XB, et al. 2007. Hepatitis B virus infection and replication in primarily cultured human fetal hepatocytes. World J. Gastroenterol. 13:1027-31
136. Fournier C, Sureau C, Coste J,Ducos J, PageauxG, et al. 1998. In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J. Gen. Virol. 79:2367-74
137. Schulze-Bergkamen H, Untergasser A, Dax A, Vogel H, Buchler P, et al. 2003. Primary human hepatocytes-a valuable tool for investigation of apoptosis and hepatitis B virus infection. J. Hepatol. 38:736-44
138. Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR. 1994. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 202:606-14
139. Tam AW, White R, Yarbough PO,Murphy BJ, McAtee CP, et al. 1997. In vitro infection and replication of hepatitis E virus in primary cynomolgus macaque hepatocytes. Virology 238:94-102
140. Zhao XP, Tang ZY, Klumpp B, Wolff-Vorbeck G, Barth H, et al. 2002. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. J. Clin. Investig. 109:221-32
141. von Weizsäcker F, Kock J, MacNelly S, Ren S, Blum HE, Nassal M. 2004. The tupaia model for the study of hepatitis B virus: direct infection and HBV genome transduction of primary tupaia hepatocytes. Methods Mol. Med. 96:153-61
142. Gripon P, Diot C, Theze N, Fourel I, Loreal O, et al. 1988. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J. Virol. 62:4136-43
143. Buck M. 2008. Direct infection and replication of naturally occurring hepatitis C virus genotypes 1, 2, 3 and 4 in normal human hepatocyte cultures. PLoS ONE 3:e2660
144. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. 1999. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 96:12766-71
145. Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, et al. 2011. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 17:589-95
146. Nahmias Y, Casali M, Barbe L, Berthiaume F, YarmushML. 2006. Liver endothelial cells promote LDLR expression and the uptake of HCV-like particles in primary rat and human hepatocytes. Hepatology 43:257-65
147. Banaudha K,Orenstein JM, KorolnekT, St LaurentGCIII, Wakita T, Kumar A. 2010. Primary hepatocyte culture supports hepatitisCvirus replication: amodel for infection-associated hepatocarcinogenesis. Hepatology 51:1922-32
148. Zhou M, Zhao F, Li J, Cheng Z, Tian X, et al. 2014. Long-term maintenance of human fetal hepatocytes and prolonged susceptibility toHBVinfection by co-culturewith non-parenchymal cells. J. Virol.Methods 195:185-93
149. HardingMJ, Lepus CM, Gibson TF, Shepherd BR, Gerber SA, et al. 2010. An implantable vascularized protein gel construct that supports human fetal hepatoblast survival and infection by hepatitis C virus in mice. PLoS ONE 5:e9987
150. Ploss A, Khetani SR, Jones CT, Syder AJ, Trehan K, et al. 2010. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc. Natl. Acad. Sci. USA 107:3141-45
151. Jones CT, Catanese MT, Law LMJ, Khetani SR, Syder AJ, et al. 2010. Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat. Biotechnol. 28:167-71
152. March S, Ng S, Velmurugan S, Galstian A, Shan J, et al. 2013. A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe 14:104-15
153. Farkas D, Tannenbaum SR. 2005. In vitro methods to study chemically induced hepatotoxicity: a literature review. Curr. Drug Metab. 6:111-25
154. Lagaye S, Shen H, Saunier B, Nascimbeni M, Gaston J, et al. 2012. Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection. Hepatology 56:861-72
155. Yoshida T, Takayama K, Kondoh M, Sakurai F, Tani H, et al. 2011. Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection. Biochem. Biophys. Res. Commun. 416:119-24
156. WuX, Robotham JM, Lee E,Dalton S, Kneteman NM, et al. 2012. Productive hepatitisCvirus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog. 8:e1002617
157. Schwartz RE,TrehanK, Andrus L, Sheahan TP, Ploss A, et al. 2012. Modeling hepatitisCvirus infection using human induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 109:2544-48
158. Roelandt P, Obeid S, Paeshuyse J, Vanhove J, Van Lommel A, et al. 2012. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J. Hepatol. 57:246-51
159. Schwartz RE, Fleming HE, Khetani SR, Bhatia SN. 2014. Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol. Adv. 32:504-13
160. Shan J, Schwartz RE, Ross NT, Logan DJ, Duncan SA, et al. 2013. Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat. Chem. Biol. 9:514-20
161. Vallier L. 2014. Heps with pep: direct reprogramming into human hepatocytes. Cell Stem Cell 3:267-69
162. Zhu S, Rezyani M, Harbell J, Mattis AN, Wolfe AR, et al. 2014. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature 508:93-97
163. LegrandN, Ploss A, Balling R, Becker PD, Borsotti C, et al. 2009. Humanizedmice formodeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 6:5-9
164. Bukh J. 2012. Animal models for the study of hepatitis C virus infection and related liver disease. Gastroenterology 142:1279-87
165. Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, et al. 2011. A genetically humanized mouse model for hepatitis C virus infection. Nature 474:208-11
166. Dorner M, Horwitz JA, Donovan BM, Labitt RN, Budell WC, et al. 2013. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 501:237-41
167. Bitzegeio J, Bankwitz D, Hueging K, Haid S, Brohm C, et al. 2010. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. PLoS Pathog. 6:e1000978
168. Flaim CJ, Chien S, Bhatia SN. 2005. An extracellular matrix microarray for probing cellular differentiation. Nat. Methods 2:119-25
169. Flaim CJ, Teng D, Chien S, Bhatia SN. 2008. Combinatorial signaling microenvironments for studying stem cell fate. Stem Cells Dev. 17:29-39
170. Lee MY, Kumar RA, Sukumaran SM, Hogg MG, Clark DS, Dordick JS. 2008. Three-dimensional cellular microarray for high-throughput toxicology assays. Proc. Natl. Acad. Sci. USA 105:59-63
171. Deiss F,Mazzeo A,Hong E, IngberDE, Derda R,WhitesidesGM. 2013. Platform for high-throughput testing of the effect of soluble compounds on 3D cell cultures. Anal. Chem. 85:8085-94
172. Mali P, Yang L, Esvelt KM, Aach J, Guell M, et al. 2013. RNA-guided human genome engineering via Cas9. Science 339:823-26
173. Hockemeyer D, Wang H, Kiani S, Lai CS,Gao Q, et al. 2011. Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 29:731-34
174. Patel SJ, King KR, Casali M, Yarmush ML. 2009. DNA-triggered innate immune responses are propagated by gap junction communication. Proc. Natl. Acad. Sci. USA 106:12867-72
175. Kwong GA, vonMaltzahn G,Murugappan G, Abudayyeh O,Mo S, et al. 2013. Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat. Biotechnol. 31:63-70
176. Miyata T, Uragami T,Nakamae K. 2002. Biomolecule-sensitive hydrogels. Adv. Drug Deliv. Rev. 54:79-98
177. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang ZP, et al. 1996. Laser capture microdissection. Science 274:998-1001
178. Kalantari M, Garcia-Carranca A,Morales-VazquezCD, ZunaR, Perez MontielD, et al. 2009. Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation. Virology 390:261-67
179. Lovatt D, Ruble BK, Lee J, Dueck H, Kim TK, et al. 2014. Transcriptome in vivo analysis (TIVA) of spatially defined single cells in live tissue. Nat. Methods 11:190-96
180. Kloxin AM, Tibbitt MW, Anseth KS. 2010. Synthesis of photodegradable hydrogels as dynamically tunable cell culture platforms. Nat. Protoc. 5:1867-87
181. Li CY, Wood DK, Huang JH, Bhatia SN. 2013. Flow-based pipeline for systematic modulation and analysis of 3D tumor microenvironments. Lab Chip 13:1969-78
182. Tan JKH, Watanabe T. 2010. Artificial engineering of secondary lymphoid organs. Adv. Immunol. 105:131-57
183. Breiner KM, SchallerH, Knolle PA. 2001. Endothelial cell-mediated uptake of a hepatitis B virus: a new concept of liver targeting of hepatotropic microorganisms. Hepatology 34:803-8
184. DalrympleNA, Mackow ER. 2012. Endothelial cells elicit immune-enhancing responses to dengue virus infection. J. Virol. 86:6408-15
185. Gardner JP, Durso RJ, Arrigale RR, Donovan GP, Maddon PJ, et al. 2003. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc. Natl. Acad. Sci. USA 100:4498-503
186. Tarran R, Button B, Picher M, Paradiso AM, Ribeiro CM, et al. 2005. Normal and cystic fibrosis airway surface liquid homeostasis-the effects of phasic shear stress and viral infections. J. Biol. Chem. 280:35751-59
187. Shi ZD, Tarbell JM. 2011. Fluid flow mechanotransduction in vascular smooth muscle cells and fibroblasts. Ann. Biomed. Eng. 39:1608-19
188. DuRose JB, Li J, Chien S, Spector DH. 2012. Infection of vascular endothelial cells with human cytomegalovirus under fluid shear stress reveals preferential entry and spread of virus in flow conditions simulating atheroprone regions of the artery. J. Virol. 86:13745-55
189. Mueller AJ, Filipe-Santos O, Eberl G, Aebischer T, Spaeth GF, Bousso P. 2012. CD4+ T cells rely on a cytokine gradient to control intracellular pathogens beyond sites of antigen presentation. Immunity 37:147-57
190. Xu N, Zhang ZF, Wang L, Gao B, Pang DW, et al. 2012. A microfluidic platform for real-time and in situ monitoring of virus infection process. Biomicrofluidics 6:34122
191. Zhu Y, Warrick JW, Haubert K, Beebe DJ, Yin J. 2009. Infection on a chip: a microscale platform for simple and sensitive cell-based virus assays. Biomed. Microdevices 11:565-70
192. Akin D, Li HB, Bashir R. 2004. Real-time virus trapping and fluorescent imaging inmicrofluidic devices. Nano Lett. 4:257-59
193. Costello DA, Millet JK, Hsia CY, Whittaker GR, Daniel S. 2013. Single particle assay of coronavirus membrane fusion with proteinaceous receptor-embedded supported bilayers. Biomaterials 34:7895-904
194. Schudel BR, Harmon B, Abhyankar VV, Pruitt BW, Negrete OA, Singh AK. 2013. Microfluidic platforms for RNA interference screening of virus-host interactions. Lab Chip 13:811-17
195. Algar WR, Prasuhn DE, Stewart MH, Jennings TL, Blanco-Canosa JB, et al. 2011. The controlled display of biomolecules on nanoparticles: a challenge suited to bioorthogonal chemistry. Bioconjug. Chem. 22:825-58
196. Gregory A, Stenzel MH. 2012. Complex polymer architectures via RAFT polymerization: from fundamental process to extending the scope using click chemistry and nature's building blocks. Prog. Polymer Sci. 37:38-105
197. Wang WW, Khetani SR, Krzyzewski S, Duignan DB, Obach RS. 2010. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites. Drug Metab. Dispos. 38:1900-5
198. Ungrin MD, Joshi C, Nica A, Bauwens C, Zandstra PW. 2008. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS ONE 3:e1565
199. LovettM, Lee K, Edwards A, Kaplan DL. 2009. Vascularization strategies for tissue engineering. Tissue Eng. B 15:353-70
200. Morinet F, Casetti L, Francois JH, Capron C, Pillet S. 2013. Oxygen tension level and human viral infections. Virology 444:31-36
201. Hanjaya-Putra D, Bose V, Shen YI, Yee J, Khetan S, et al. 2011. Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood 118:804-15
202. Samuel R, DaheronL,Liao S, VardamT,KamounWS,et al. 2013. Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 110:12774-79
203. Wu W, Hansen CJ, Aragon AM, Geubelle PH, White SR, Lewis JA. 2010. Direct-write assembly of biomimetic microvascular networks for efficient fluid transport. Soft Matter 6:739-42
204. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, et al. 2006. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80:5308-20
205. Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, et al. 2012. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc. Natl. Acad. Sci. USA 109:14610-15
206. Tanimizu N, Miyajima A, Mostov KE. 2007. Liver progenitor cells develop cholangiocyte-type epithelial polarity in three-dimensional culture. Mol. Biol. Cell 18:1472-79
207. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, et al. 2010. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51:297-305
208. Goldman O, Han S, Sourrisseau M, Dziedzic N, Hamou W, et al. 2013. KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development. Cell Stem Cell 12:748-60
209. DischerDE, Mooney DJ, Zandstra PW. 2009. Growth factors, matrices, and forces combine and control stem cells. Science 324:1673-77
210. Fernandes TG, Kwon SJ, Bale SS, Lee MY, Diogo MM, et al. 2010. Three-dimensional cell culture microarray for high-throughput studies of stem cell fate. Biotechnol. Bioeng. 106:106-18